About Jinnouchi Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Jinnouchi Hospital
During the past decade, Jinnouchi Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
2010-11-11
2018-08-21
Completed
6,103
Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus
2015-05-12
2017-06-16
Completed
880
A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
2019-03-30
2021-02-16
Completed
443
A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
2019-08-30
2021-01-13
Completed
475
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
2020-05-29
2024-10-17
Active, not recruiting
13,299
A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
2021-04-13
2023-04-29
Active, not recruiting
585
A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin
2022-03-08
2024-05-14
Active, not recruiting
986
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time
2022-06-03
2024-06-10
Active, not recruiting
912
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Jinnouchi Hospital"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Jinnouchi Hospital
According to Clinical.Site data, the most researched conditions in "Jinnouchi Hospital" are
"Diabetes Mellitus, Type 2" (3 trials), "Type 2 Diabetes" (3 trials), "Diabetes" (2 trials), "Type 2 Diabetes Mellitus" (2 trials) and "Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Jinnouchi Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Jinnouchi Hospital
Most popular intervention types in "Jinnouchi Hospital" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Insulin Degludec" (3 trials), "Insulin Efsitora Alfa" (3 trials), "Tirzepatide" (3 trials), "Dulaglutide" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Jinnouchi Hospital
The vast majority of trials in "Jinnouchi Hospital" are
9 trials for "All" genders.
Clinical Trials Status at Jinnouchi Hospital
Currently, there are NaN active trials in "Jinnouchi Hospital".
undefined are not yet recruiting,
undefined are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Jinnouchi Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Jinnouchi Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".